دورية أكاديمية
أعرض في EDS

Postpartum Glucose Tolerance Testing Among Patients With Gestational Diabetes During the Coronavirus Disease 2019 Pandemic.

التفاصيل البيبلوغرافية
العنوان: Postpartum Glucose Tolerance Testing Among Patients With Gestational Diabetes During the Coronavirus Disease 2019 Pandemic.
المؤلفون: Youssefzadeh AC; Department of Obstetrics and Gynecology, Los Angeles County University of Southern California Medical Center, Los Angeles, USA., Aberle LS; Department of Obstetrics and Gynecology, Los Angeles County University of Southern California Medical Center, Los Angeles, USA., Gordon B; Department of Obstetrics and Gynecology, Los Angeles County University of Southern California Medical Center, Los Angeles, USA., Sriprasert I; Department of Obstetrics and Gynecology, Los Angeles County University of Southern California Medical Center, Los Angeles, USA., Sacks DA; Department of Obstetrics and Gynecology, Los Angeles County University of Southern California Medical Center, Los Angeles, USA., Martin B; Department of Obstetrics and Gynecology, Huntington Hospital, Pasadena, USA., Sequeira P; Department of Endocrinology, Los Angeles County University of Southern California Medical Center, Los Angeles, USA., Lee RH; Department of Obstetrics and Gynecology, Los Angeles County University of Southern California Medical Center, Los Angeles, USA.
المصدر: Cureus [Cureus] 2023 Jan 25; Vol. 15 (1), pp. e34210. Date of Electronic Publication: 2023 Jan 25 (Print Publication: 2023).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Palo Alto, CA : Cureus, Inc.
مستخلص: Introduction The impact of the coronavirus disease (COVID-19) COVID-19 pandemic on the care of pregnant patients with gestational diabetes (GDM) is largely unreported. The objective of this study was to compare the completion of postpartum oral glucose tolerance testing (GTT) prior to and during the COVID-19 pandemic among patients with GDM. Methods This was a retrospective review of patients diagnosed with GDM between April 2019 and March 2021. Medical records of patients diagnosed with GDM prior to and during the pandemic were compared. The primary outcome was the difference in the completion of postpartum GTT prior to and during the COVID-19 pandemic. Completion was defined as testing between four weeks to six months postpartum. Secondary objectives were: 1) to compare maternal and neonatal outcomes prior to and during the pandemic among patients with GDM, and 2) to compare pregnancy characteristics and outcomes by compliance with postpartum GTT. Results There were 185 patients included in the study, of whom 83 (44.9%) delivered prior to the pandemic and 102 (55.1%) delivered during the pandemic. There was no difference in completion of postpartum diabetes testing prior, compared to during the pandemic (27.7% vs 33.3%, p=0.47). Postpartum diagnosis of pre-diabetes and type two diabetes mellitus (T2DM) did not differ between groups (p=0.36 and p=1.00, respectively). Patients who completed postpartum testing were less likely to have preeclampsia with severe features compared to patients who did not (OR 0.08, 95% CI 0.01-0.96, p=0.02). Conclusion Completion of postpartum testing for T2DM remained poor prior to and during the COVID-19 pandemic. These findings underscore the need for the adoption of more accessible methods of postpartum testing for T2DM among patients with GDM.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2023, Youssefzadeh et al.)
References: Prev Chronic Dis. 2011 Nov;8(6):A124. (PMID: 22005617)
J Perinatol. 2018 Feb;38(2):118-121. (PMID: 29048411)
Diabetes Res Clin Pract. 2014 Nov;106(2):236-40. (PMID: 25271112)
Diabetes Care. 2022 Jan 1;45(Suppl 1):S232-S243. (PMID: 34964864)
Obstet Gynecol. 2018 Feb;131(2):406-408. (PMID: 29370044)
Prim Care Diabetes. 2015 Aug;9(4):244-52. (PMID: 25899304)
Diabetes Res Clin Pract. 2015 Apr;108(1):72-7. (PMID: 25661662)
J Womens Health (Larchmt). 2018 Apr;27(4):498-502. (PMID: 29211594)
J Womens Health (Larchmt). 2019 Aug;28(8):1116-1123. (PMID: 30628865)
Curr Med Res Opin. 2021 Oct;37(10):1705-1717. (PMID: 34281467)
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):391-395. (PMID: 33571889)
Diabetes Metab Syndr. 2017 Dec;11 Suppl 2:S703-S712. (PMID: 28571777)
Medicina (Kaunas). 2021 Apr 15;57(4):. (PMID: 33920937)
J Matern Fetal Neonatal Med. 2018 Jun;31(12):1607-1612. (PMID: 28423981)
Obstet Gynecol. 2018 Jul;132(1):193-198. (PMID: 29889746)
BMJ. 2020 May 13;369:m1361. (PMID: 32404325)
N Engl J Med. 2002 Feb 7;346(6):393-403. (PMID: 11832527)
Diabetes Care. 2019 Jan;42(Suppl 1):S13-S28. (PMID: 30559228)
Diabetes Res Clin Pract. 2020 Aug;166:108309. (PMID: 32650034)
Am J Obstet Gynecol. 2020 Sep;223(3):439.e1-439.e7. (PMID: 32470456)
فهرسة مساهمة: Keywords: covid-19; gestational diabetes; postpartum care; postpartum glucose tolerance testing; types 2 diabetes
تواريخ الأحداث: Date Created: 20230227 Latest Revision: 20230228
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9957679
DOI: 10.7759/cureus.34210
PMID: 36843799
قاعدة البيانات: MEDLINE
الوصف
تدمد:2168-8184
DOI:10.7759/cureus.34210